Longitudinal MRI Temporal Transformer Fusion Model for Predicting Induction Chemotherapy Efficacy in Locally Advanced Nasopharyngeal Carcinoma
Open Access
- 1 June 2026
- journal article
- research article
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 25
Abstract
Introduction: Induction chemotherapy (IC) represents a standard treatment approach for locally advanced nasopharyngeal carcinoma (LA-NPC), yet marked interpatient heterogeneity in treatment response persists. This study sought to develop and evaluate a temporal Transformer–based fusion model integrating baseline pretreatment and early intratreatment MRI to facilitate early risk stratification and inform individualized therapeutic management. Materials and Methods: In this retrospective multicenter study, 488 patients with pathologically confirmed LA-NPC were enrolled from two institutions. All patients underwent induction chemotherapy and received contrast-enhanced T1-weighted imaging (CE-T1WI) before treatment initiation (Pre-IC) and at an early post-treatment time point (Post-IC). A dual-branch independent network architecture with Twins-SVT as the backbone was implemented to separately extract deep learning features from Pre-IC and Post-IC CE-T1WI images. Subsequently, an attention-based temporal Transformer fusion module was designed to model nonlinear longitudinal interactions and dynamic evolutionary patterns between pre- and post-treatment tumor representations, yielding a longitudinal temporal fusion predictive model. Gradient-weighted class activation mapping (Grad-CAM) was applied to enhance interpretability through visualization of salient imaging regions. Results: The deep learning model based on Pre-IC imaging yielded an AUC of 0.844 (95% CI: 0.767–0.922) in the internal validation cohort and 0.819 (95% CI: 0.725–0.913) in the external validation cohort. The Post-IC–based model demonstrated AUCs of 0.863 (95% CI: 0.790–0.936) and 0.838 (95% CI: 0.753–0.923) in the internal and external validation cohorts, respectively. The longitudinal temporal Transformer fusion model achieved higher predictive performance, with AUCs increasing to 0.889 (95% CI: 0.824–0.955) in the internal validation cohort and 0.865 (95% CI: 0.791–0.939) in the external validation cohort. Conclusion: Compared with single–time point models, a longitudinal contrast-enhanced MRI–based temporal Transformer fusion model enabled more accurate early individualized prediction of induction chemotherapy response in patients with locally advanced nasopharyngeal carcinoma.Keywords
This publication has 36 references indexed in Scilit:
- MSRA-Net: Tumor segmentation network based on Multi-scale Residual AttentionComputers in Biology and Medicine, 2023
- Radiotherapy Alone Versus Concurrent or Adjuvant Chemoradiotherapy for Nasopharyngeal Carcinoma Patients with Negative Epstein–Barr Virus DNA after Induction ChemotherapyCancers, 2023
- 3D face-model reconstruction from a single image: A feature aggregation approach using hierarchical transformer with weak supervisionNeural Networks, 2022
- Which evaluation criteria of the short-term efficacy can better reflect the long-term outcomes for patients with nasopharyngeal carcinoma?Translational Oncology, 2022
- Deep learning for locally advanced nasopharyngeal carcinoma prognostication based on pre- and post-treatment MRIComputer Methods and Programs in Biomedicine, 2022
- Baseline MRI-based radiomics model assisted predicting disease progression in nasopharyngeal carcinoma patients with complete response after treatmentCancer Imaging, 2022
- Predictive Value of a Combined Model Based on Pre-Treatment and Mid-Treatment MRI-Radiomics for Disease Progression or Death in Locally Advanced Nasopharyngeal CarcinomaFrontiers in Oncology, 2021
- Imaging biomarkers for evaluating tumor response: RECIST and beyondBiomarker Research, 2021
- MRI based radiomics in nasopharyngeal cancer: Systematic review and perspectives using radiomic quality score (RQS) assessmentEuropean Journal of Radiology, 2021
- Nasopharyngeal carcinomaThe Lancet, 2019